Biotech

All Articles

Lykos are going to talk to FDA to reconsider its decision observing turndown of MDMA treatment for post-traumatic stress disorder

.Observing an inadequate showing for Lykos Therapeutics' MDMA prospect for post-traumatic stress dis...

AN 2 one-halfs headcount, stops phase 3 trial after records disappoint

.AN2 Therapies is reassessing its service in response to poor midphase information, swearing to give...

Merck pays $700M for bispecific, snooping autoimmune position and odds to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 thousand ahead of time to challenge Amgen in a blood str...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences almost an FDA selection for its own liver condition medication seladelpa...

' All hands on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks can observe the companies setting up outdoors tents at basecamp...

Entero giving up workers, leaving workplace and also stopping briefly R&ampD

.Bed Liquidators has actually switched Entero Rehabs white colored as a sheet. The collector ordered...

Exelixis drops ADC after choosing it's no match for Tivdak

.Exelixis is actually quiting on its own tissue factor (TF)- targeting antibody-drug conjugate after...

Relay dislikes SHP2 inhibitor after Genentech leaves

.Three full weeks after Roche's Genentech unit walked away from an SHP2 prevention contract, Relay T...

Stoke's Dravet syndrome med discharged of partial clinical hold

.Stoke Rehabs' Dravet disorder drug has been freed from a partial hold, getting rid of the technique...

Fierce Biotech's Gabrielle Masson offers Tough 15 at NYSE

.Ferocious Biotech Affiliate Publisher Gabrielle Masson presented the 2024 training class of Brutal ...